GeneReach Biotechnology (Taiwan) Statistic Functions Variance

4171 Stock  TWD 26.75  0.50  1.83%   
GeneReach Biotechnology statistic functions tool provides the execution environment for running the Variance function and other technical functions against GeneReach Biotechnology. GeneReach Biotechnology value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Variance function function is designed to identify and follow existing trends. GeneReach Biotechnology statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period and Deviations to execute this module.

Function
Time Period
Deviations
Execute Function
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. GeneReach Biotechnology Variance is a measurement of the price spread between periods of GeneReach Biotechnology price series.

GeneReach Biotechnology Technical Analysis Modules

Most technical analysis of GeneReach Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GeneReach from various momentum indicators to cycle indicators. When you analyze GeneReach charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About GeneReach Biotechnology Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of GeneReach Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of GeneReach Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing GeneReach Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GeneReach Biotechnology's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of GeneReach Biotechnology's intrinsic value. In addition to deriving basic predictive indicators for GeneReach Biotechnology, we also check how macroeconomic factors affect GeneReach Biotechnology price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Hype
Prediction
LowEstimatedHigh
25.5926.7527.91
Details
Intrinsic
Valuation
LowRealHigh
24.0833.1434.30
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GeneReach Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GeneReach Biotechnology's short interest history, or implied volatility extrapolated from GeneReach Biotechnology options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Momentum Idea
Momentum
Invested over 50 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Business Services Idea
Business Services
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested few shares
Impulse Idea
Impulse
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Electronic Equipment Idea
Electronic Equipment
Invested few shares
Millennials Best Idea
Millennials Best
Invested few shares

Additional Tools for GeneReach Stock Analysis

When running GeneReach Biotechnology's price analysis, check to measure GeneReach Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneReach Biotechnology is operating at the current time. Most of GeneReach Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneReach Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneReach Biotechnology's price. Additionally, you may evaluate how the addition of GeneReach Biotechnology to your portfolios can decrease your overall portfolio volatility.